ARCHIVES

In Brief: NCI Scientist Accused Of Taking ‘Payoffs’ Forom Drug Firms; GM-CS Wins FDA Approval

This article is from The Cancer Letter archive.

Vol. 17 No. 11 | March 15, 1991

Download PDF Visit The Full Archive

Related Articles

New NCI division For Center, Training, Organ Systems, Construction Seen As Likely Prospect

April 17, 1987

DCT Board Approves Recompetition Of Drug Development Contracts

June 25, 1993

New FDA Commisioner’s Top Priorities: FDAMA Implimitation, Agency’s Science

January 8, 1999

Centers See Trend To Integrate Control Service With Science

February 18, 1983

NCI Funded Over 4,500 Grants Last Year, Half Its $3B Budget.

January 19, 2001

Activists To Seek $660 Million For Breast Cancer Research, Legislation To Declare An “Epidemic”

February 12, 1993